Emily King is a statistician and computational genomics scientist with a decade of experience translating complex genetic datasets into actionable target insights at AbbVie. With a PhD in Statistics and a background in Bayesian methods and hidden Markov models, she specializes in GWAS/PheWAS integration, CRISPR and cell-painting screen analysis, and predictive modeling for drug target discovery. Her work moves between rigorous method development (including NGS-focused Bayesian inference) and pragmatic data integration across biomedical resources. Based in the Chicago area, she combines academic rigor from NSF-supported research with industry impact, uniquely bridging statistical theory and high-throughput experimental data to prioritize therapeutic targets.
10 years of coding experience
6 years of employment as a software developer
Doctor of Philosophy - PhD, Statistics, Doctor of Philosophy - PhD, Statistics at Iowa State University
Master of Science (MS), Geological and Earth Sciences/Geosciences, Master of Science (MS), Geological and Earth Sciences/Geosciences at The University of Chicago
Contributions:17 commits, 1 push, 1 branch in 2 months
Find and Hire Top DevelopersWe’ve analyzed the programming source code of over 60 million software developers on GitHub and scored them by 50,000 skills. Sign-up on Prog,AI to search for software developers.